{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:08:45Z","timestamp":1784128125330,"version":"3.55.0"},"reference-count":33,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"vor","delay-in-days":271,"URL":"http:\/\/www.diabetesjournals.org\/site\/license"}],"funder":[{"name":"Nowlin Family Trust of the InFaith Foundation"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,7,1]]},"abstract":"<jats:p>A mechanistic cause for Mauriac syndrome, a syndrome of growth failure and delayed puberty associated with massive liver enlargement from glycogen deposition in children with poorly controlled type 1 diabetes, is unknown. We discovered a mutation in the catalytic subunit of liver glycogen phosphorylase kinase in a patient with Mauriac syndrome whose liver extended into his pelvis. Glycogen phosphorylase kinase activates glycogen phosphorylase, the enzyme that catalyzes the first step in glycogen breakdown. We show that the mutant subunit acts in a dominant manner to completely inhibit glycogen phosphorylase kinase enzyme activity and that this interferes with glycogenolysis causing increased levels of glycogen in human liver cells. It is known that even normal blood glucose levels physiologically inhibit glycogen phosphorylase to diminish glucose release from the liver when glycogenolysis is not needed. The patient\u2019s mother possessed the same mutant glycogen phosphorylase kinase subunit, but did not have diabetes or hepatomegaly. His father had childhood type 1 diabetes in poor glycemic control, but lacked the mutation and had neither hepatomegaly nor growth failure. This case proves that the effect of a mutant enzyme of glycogen metabolism can combine with hyperglycemia to directly hyperinhibit glycogen phosphorylase, in turn blocking glycogenolysis causing the massive liver in Mauriac disease.<\/jats:p>","DOI":"10.2337\/db16-0099","type":"journal-article","created":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T02:32:52Z","timestamp":1459909972000},"page":"2051-2059","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":51,"title":["Discovery of a Genetic Metabolic Cause for Mauriac Syndrome in Type 1 Diabetes"],"prefix":"10.2337","volume":"65","author":[{"given":"Michael J.","family":"MacDonald","sequence":"first","affiliation":[{"name":"Childrens Diabetes Center, University of Wisconsin School of Medicine and Public Health, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noaman M.","family":"Hasan","sequence":"additional","affiliation":[{"name":"Childrens Diabetes Center, University of Wisconsin School of Medicine and Public Health, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israr-ul H.","family":"Ansari","sequence":"additional","affiliation":[{"name":"Childrens Diabetes Center, University of Wisconsin School of Medicine and Public Health, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Longacre","sequence":"additional","affiliation":[{"name":"Childrens Diabetes Center, University of Wisconsin School of Medicine and Public Health, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy A.","family":"Kendrick","sequence":"additional","affiliation":[{"name":"Childrens Diabetes Center, University of Wisconsin School of Medicine and Public Health, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Stoker","sequence":"additional","affiliation":[{"name":"Childrens Diabetes Center, University of Wisconsin School of Medicine and Public Health, Madison, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2016,4,5]]},"reference":[{"key":"2022031210464399500_B1","first-page":"402","article-title":"Gros ventre, hepatomegalie, troubles de croissance chez les enfants diabetiques traites depuis plusiers annee par l\u2019insuline","volume":"26","author":"Mauriac","year":"1930","journal-title":"Gaz Hebd Med Bordeaux"},{"key":"2022031210464399500_B2","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.diabres.2009.12.016","article-title":"Genetic association of the neuropilin-1 gene with type 1 diabetes in children: neuropilin-1 expression in pancreatic islets","volume":"87","author":"Hasan","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031210464399500_B3","doi-asserted-by":"crossref","first-page":"35359","DOI":"10.1074\/jbc.M109.040394","article-title":"Chronic reduction of the cytosolic or mitochondrial NAD(P)-malic enzyme does not affect insulin secretion in a rat insulinoma cell line","volume":"284","author":"Brown","year":"2009","journal-title":"J Biol Chem"},{"key":"2022031210464399500_B4","doi-asserted-by":"crossref","first-page":"30596","DOI":"10.1074\/jbc.M702732200","article-title":"Feasibility of pathways for transfer of acyl groups from mitochondria to the cytosol to form short chain acyl-CoAs in the pancreatic beta cell","volume":"282","author":"MacDonald","year":"2007","journal-title":"J Biol Chem"},{"key":"2022031210464399500_B5","doi-asserted-by":"crossref","first-page":"18383","DOI":"10.1074\/jbc.M111.241182","article-title":"Differences between human and rodent pancreatic islets: low pyruvate carboxylase, ATP citrate lyase, and pyruvate carboxylation and high glucose-stimulated acetoacetate in human pancreatic islets","volume":"286","author":"MacDonald","year":"2011","journal-title":"J Biol Chem"},{"key":"2022031210464399500_B6","doi-asserted-by":"crossref","first-page":"28048","DOI":"10.1074\/jbc.M804170200","article-title":"Impaired anaplerosis and insulin secretion in insulinoma cells caused by small interfering RNA-mediated suppression of pyruvate carboxylase","volume":"283","author":"Hasan","year":"2008","journal-title":"J Biol Chem"},{"key":"2022031210464399500_B7","doi-asserted-by":"crossref","first-page":"e9815","DOI":"10.1371\/journal.pone.0009815","article-title":"Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A","volume":"5","author":"Fernandes","year":"2010","journal-title":"PLoS One"},{"key":"2022031210464399500_B8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0003-2697(74)90248-6","article-title":"A comparison of three methods of glycogen measurement in tissues","volume":"60","author":"Passonneau","year":"1974","journal-title":"Anal Biochem"},{"key":"2022031210464399500_B9","first-page":"177","article-title":"A collection of metabolite assays, glycogen","volume-title":"Enzymatic Analysis: A Practical Guide","author":"Passonneau","year":"1993"},{"key":"2022031210464399500_B10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.bi.45.070176.001123","article-title":"The control of glycogen metabolism in the liver","volume":"45","author":"Hers","year":"1976","journal-title":"Annu Rev Biochem"},{"key":"2022031210464399500_B11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ymgme.2011.05.010","article-title":"Liver glycogen storage diseases due to phosphorylase system deficiencies: diagnosis thanks to non invasive blood enzymatic and molecular studies","volume":"104","author":"Davit-Spraul","year":"2011","journal-title":"Mol Genet Metab"},{"key":"2022031210464399500_B12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/bj3360019","article-title":"Specific features of glycogen metabolism in the liver","volume":"336","author":"Bollen","year":"1998","journal-title":"Biochem J"},{"key":"2022031210464399500_B13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/GIM.0b013e3181d94eaa","article-title":"Molecular analysis of the AGL gene: identification of 25 novel mutations and evidence of genetic heterogeneity in patients with glycogen storage disease type III","volume":"12","author":"Goldstein","year":"2010","journal-title":"Genet Med"},{"key":"2022031210464399500_B14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nrendo.2010.189","article-title":"Glycogen storage disease type I and G6Pase-\u03b2 deficiency: etiology and therapy","volume":"6","author":"Chou","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"2022031210464399500_B15","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1172\/JCI30443","article-title":"Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta","volume":"117","author":"Cheung","year":"2007","journal-title":"J Clin Invest"},{"key":"2022031210464399500_B16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa0805051","article-title":"A syndrome with congenital neutropenia and mutations in G6PC3","volume":"360","author":"Boztug","year":"2009","journal-title":"N Engl J Med"},{"key":"2022031210464399500_B17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymgme.2007.06.007","article-title":"Glycogen storage disease type IX: high variability in clinical phenotype","volume":"92","author":"Beauchamp","year":"2007","journal-title":"Mol Genet Metab"},{"key":"2022031210464399500_B18","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/hmg\/6.7.1109","article-title":"Autosomal glycogenosis of liver and muscle due to phosphorylase kinase deficiency is caused by mutations in the phosphorylase kinase beta subunit (PHKB)","volume":"6","author":"Burwinkel","year":"1997","journal-title":"Hum Mol Genet"},{"key":"2022031210464399500_B19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s004390050715","article-title":"Variability of biochemical and clinical phenotype in X-linked liver glycogenosis with mutations in the phosphorylase kinase PHKA2 gene","volume":"102","author":"Burwinkel","year":"1998","journal-title":"Hum Genet"},{"key":"2022031210464399500_B20","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1203\/01.PDR.0000088069.09275.10","article-title":"Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene","volume":"54","author":"Burwinkel","year":"2003","journal-title":"Pediatr Res"},{"key":"2022031210464399500_B21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymgme.2013.12.008","article-title":"Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene","volume":"111","author":"Bali","year":"2014","journal-title":"Mol Genet Metab"},{"key":"2022031210464399500_B22","first-page":"Unit7.20","article-title":"Predicting functional effect of human missense mutations using PolyPhen-2","volume":"Chapter 7","author":"Adzhubei","year":"2013","journal-title":"Curr Protoc Hum Genet"},{"key":"2022031210464399500_B23","doi-asserted-by":"crossref","first-page":"36651","DOI":"10.1074\/jbc.M112.412874","article-title":"Structure and location of the regulatory \u03b2 subunits in the (\u03b1\u03b2\u03b3\u03b4)4 phosphorylase kinase complex","volume":"287","author":"Nadeau","year":"2012","journal-title":"J Biol Chem"},{"key":"2022031210464399500_B24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0969-2126(01)00691-8","article-title":"Three-dimensional structure of phosphorylase kinase at 22 A resolution and its complex with glycogen phosphorylase b","volume":"10","author":"V\u00e9nien-Bryan","year":"2002","journal-title":"Structure"},{"key":"2022031210464399500_B25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1440-1754.2000.00547.x","article-title":"Hepatic glycogenosis: reversible hepatomegaly in type 1 diabetes","volume":"36","author":"Munns","year":"2000","journal-title":"J Paediatr Child Health"},{"key":"2022031210464399500_B26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jdiacomp.2007.11.004","article-title":"Clinical resolution of glycogenic hepatopathy following improved glycemic control","volume":"22","author":"Hudacko","year":"2008","journal-title":"J Diabetes Complications"},{"key":"2022031210464399500_B27","first-page":"269","article-title":"Glycogenic hepatopathy: a rare disease that can appear and resolve rapidly in parallel with glycemic control","volume":"14","author":"Saadi","year":"2012","journal-title":"Isr Med Assoc J"},{"key":"2022031210464399500_B28","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/00000478-200604000-00012","article-title":"Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus","volume":"30","author":"Torbenson","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"2022031210464399500_B29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1399-5448.2009.00627.x","article-title":"Prevalence of hepatic abnormalities in a cohort of Egyptian children with type 1 diabetes mellitus","volume":"11","author":"El-Karaksy","year":"2010","journal-title":"Pediatr Diabetes"},{"key":"2022031210464399500_B30","first-page":"557","volume-title":"Lehninger Principles of Biochemistry","author":"Nelson","year":"2000","edition":"3rd ed"},{"key":"2022031210464399500_B31","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/dmr.5610030107","article-title":"Control of glycogen synthesis in health and disease","volume":"3","author":"Stalmans","year":"1987","journal-title":"Diabetes Metab Rev"},{"key":"2022031210464399500_B32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1566524024605761","article-title":"Glycogen and its metabolism","volume":"2","author":"Roach","year":"2002","journal-title":"Curr Mol Med"},{"key":"2022031210464399500_B33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1432-1033.1974.tb03847.x","article-title":"The interaction of liver phosphorylase a with glucose and AMP","volume":"49","author":"Stalmans","year":"1974","journal-title":"Eur J Biochem"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/diabetes.diabetesjournals.org\/syndication\/doi\/10.2337\/db16-0099","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/65\/7\/2051\/600496\/db160099.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/65\/7\/2051\/600496\/db160099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:49:58Z","timestamp":1667407798000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/65\/7\/2051\/16288\/Discovery-of-a-Genetic-Metabolic-Cause-for-Mauriac"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,5]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,4,5]]},"published-print":{"date-parts":[[2016,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db16-0099","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,5]]}}}